| STUDY PERIOD | ||||
---|---|---|---|---|---|
Enrollment | Allocation | Baseline (t0) | 2Â months (t1) | 6Â months (t2) | |
Eligibility screen | X | Â | Â | Â | Â |
Informed consent | X | Â | Â | Â | Â |
Allocation | Â | X | Â | Â | Â |
Demographic information | Â | Â | X | Â | Â |
Medical comorbidities | Â | Â | X | Â | Â |
Performance status | Â | Â | X | Â | Â |
Disease characteristics | Â | Â | X | Â | Â |
ACPa | Â | Â | X | X | X |
FACIT-Palb | Â | Â | X | X | X |
QOCc | Â | Â | X | X | X |
Hospice care utilization | Â | Â | X | X | X |
ESASd | Â | Â | X | X | X |
CES-De | Â | Â | X | X | X |
PMH/PSQ-MDf | Â | Â | X | X | X |
FAMCAREg | Â | Â | X | X | X |
Palliative and hospice care utilization | Â | Â | X | X | X |
Resource utilization | Â | Â | X | X | X |
PRAPAREh | Â | Â | X | X | X |